AstraZeneca snaps up Icosavax for $1.1 billion
Tuesday, 12 December 2023, 8:39 am
Dealmaking may be a bit lacklustre at the moment but if there is one sector that is seeing a lot of activity right now it's the biotechnology industry.
The latest deal to be announced is AstraZeneca's $1.1 acquisition of Icosavax, a US-listed developer of vaccines for respitory diseases...
Tags: AstraZeneca, Icosavax